Trial Profile
A Study of Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Apr 2019
Price :
$35
*
At a glance
- Drugs Bimatoprost (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- Acronyms LOTUS
- Sponsors Allergan
- 25 Feb 2014 New trial record